MSH5-SAPCD1
|
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
8
|
0.760 |
0.423 |
|
0.100 |
None
|
1.000 |
3
|
1
|
2008 |
2012 |
TSBP1-AS1
|
|
TSBP1 and BTNL2 antisense RNA 1
|
|
39
|
0.638 |
0.692 |
|
0.100 |
None
|
1.000 |
2
|
1
|
2009 |
2012 |
Entrez Id: |
10255 |
Gene Symbol: |
HCG9 |
HCG9
|
|
HLA complex group 9
|
|
9
|
0.700 |
0.500 |
|
0.100 |
None
|
1.000 |
2
|
1
|
2009 |
2012 |
Entrez Id: |
414777 |
Gene Symbol: |
HCG18 |
HCG18
|
|
HLA complex group 18
|
|
12
|
0.722 |
0.538 |
|
0.100 |
None
|
1.000 |
2
|
1
|
2009 |
2012 |
Entrez Id: |
414778 |
Gene Symbol: |
HCG17 |
HCG17
|
|
HLA complex group 17
|
|
12
|
0.769 |
0.346 |
|
0.100 |
None
|
1.000 |
2
|
3
|
2009 |
2012 |
HORMAD2-AS1
|
|
HORMAD2 and MTMR3 antisense RNA 1
|
|
2
|
0.839 |
0.308 |
|
0.100 |
None
|
1.000 |
1
|
7
|
2011 |
2011 |
HLA-DRB9
|
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
21
|
0.682 |
0.654 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2012 |
2012 |
Entrez Id: |
3139 |
Gene Symbol: |
HLA-L |
HLA-L
|
|
major histocompatibility complex, class I, L (pseudogene)
|
|
3
|
0.861 |
0.269 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2012 |
2012 |
RPL18P11
|
|
ribosomal protein L18 pseudogene 11
|
|
3
|
0.931 |
0.077 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2012 |
2012 |
LINC00243
|
|
long intergenic non-protein coding RNA 243
|
|
15
|
0.729 |
0.423 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2012 |
2012 |
TRIM26BP
|
|
tripartite motif containing 26B, pseudogene
|
|
4
|
0.861 |
0.269 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2012 |
2012 |
HNRNPA1P1
|
|
heterogeneous nuclear ribonucleoprotein A1 pseudogene 1
|
|
2
|
0.931 |
0.154 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2012 |
2012 |
ZNRD1ASP
|
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
12
|
0.691 |
0.538 |
|
0.110 |
None
|
1.000 |
1
|
2
|
2012 |
2016 |
Entrez Id: |
123688 |
Gene Symbol: |
HYKK |
HYKK
|
A2RU49
|
hydroxylysine kinase
|
|
6
|
0.769 |
0.346 |
7.3E-06 |
0.190 |
None
|
1.000 |
7
|
2
|
2008 |
2017 |
Entrez Id: |
101928601 |
Gene Symbol: |
MEI4 |
MEI4
|
A8MW99
|
meiotic double-stranded break formation protein 4
|
|
1
|
1.000 |
0.077 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2011 |
2011 |
Entrez Id: |
4439 |
Gene Symbol: |
MSH5 |
MSH5
|
O43196
|
mutS homolog 5
|
Nucleic acid binding
|
8
|
0.641 |
0.692 |
3.2E-11 |
0.120 |
None
|
0.800 |
3
|
1
|
2008 |
2017 |
Entrez Id: |
3992 |
Gene Symbol: |
FADS1 |
FADS1
|
O60427
|
fatty acid desaturase 1
|
|
22
|
0.582 |
0.769 |
0.37 |
0.100 |
None
|
1.000 |
1
|
2
|
2011 |
2011 |
Entrez Id: |
10211 |
Gene Symbol: |
FLOT1 |
FLOT1
|
O75955
|
flotillin 1
|
|
3
|
0.623 |
0.692 |
1.0E-08 |
0.100 |
None
|
1.000 |
1
|
1
|
2012 |
2012 |
Entrez Id: |
55937 |
Gene Symbol: |
APOM |
APOM
|
O95445
|
apolipoprotein M
|
|
6
|
0.590 |
0.769 |
9.6E-04 |
0.110 |
None
|
1.000 |
3
|
1
|
2008 |
2018 |
Entrez Id: |
9415 |
Gene Symbol: |
FADS2 |
FADS2
|
O95864
|
fatty acid desaturase 2
|
|
25
|
0.575 |
0.692 |
1.00 |
0.100 |
None
|
1.000 |
1
|
6
|
2011 |
2011 |
Entrez Id: |
11200 |
Gene Symbol: |
CHEK2 |
CHEK2
|
O96017
|
checkpoint kinase 2
|
Kinase
|
2
|
0.460 |
0.808 |
1.2E-24 |
0.500 |
None
|
1.000 |
1
|
1
|
2000 |
2017 |
Entrez Id: |
629 |
Gene Symbol: |
CFB |
CFB
|
P00751
|
complement factor B
|
|
10
|
0.532 |
0.769 |
4.7E-16 |
0.100 |
None
|
1.000 |
1
|
1
|
2012 |
2012 |
HLA-DQA2
|
P01906
|
major histocompatibility complex, class II, DQ alpha 2
|
Immune response
|
18
|
0.617 |
0.769 |
1.0E-05 |
0.100 |
None
|
1.000 |
2
|
1
|
2009 |
2012 |
HLA-DQA1
|
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
23
|
0.416 |
0.846 |
2.4E-02 |
0.120 |
None
|
1.000 |
2
|
1
|
2009 |
2017 |
HLA-DRB1
|
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
18
|
0.333 |
0.923 |
1.1E-03 |
0.160 |
None
|
1.000 |
1
|
1
|
1998 |
2019 |